The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells

Naoise C Synnott1, Stephen F Madden2, Vladimir J N Bykov3

  • 1UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

Translational Oncology
|September 10, 2018
PubMed

Insights

APR-246 reactivates mutant p53 and affects gene expression in breast cancer cells. Six genes, including SLC7A11 and TRIM16, were upregulated, suggesting potential biomarkers for treatment response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • The TP53 gene is frequently mutated in human cancers, making mutant p53 a key therapeutic target.
  • APR-246 is an investigational drug designed to reactivate mutant p53 and is in clinical trials for ovarian cancer.
  • Understanding APR-246's molecular effects on gene expression is crucial for optimizing its therapeutic application.

Purpose of the Study:

  • To investigate the effects of APR-246 on gene expression in human breast cancer cell lines using RNA-sequencing.
  • To identify genes and pathways modulated by APR-246 treatment.
  • To explore potential pharmacodynamic biomarkers for APR-246 response.

Main Methods:

  • RNA-sequencing (RNA-seq) was employed to analyze gene expression changes in three human breast cancer cell lines treated with APR-246.
  • Quantitative Polymerase Chain Reaction (qPCR) was used to validate the expression of specific p53 target genes.
  • Gene Ontology (GO) analysis was performed to identify affected biological pathways.

Main Results:

  • APR-246 treatment led to cell line-dependent gene expression changes.
  • Six genes (TRIM16, SLC7A11, TXNRD1, SRXN1, LOC344887, and SLC7A11-AS1) were consistently upregulated across all tested cell lines.
  • While canonical p53 target genes were not significantly upregulated by RNA-seq, qPCR confirmed their induction. GO analysis revealed impacts on oxidative stress, gene expression, cell proliferation, nitrosative stress, and glutathione biosynthesis.

Conclusions:

  • APR-246 exhibits a dual mechanism of action, involving mutant p53 reactivation and redox modulation.
  • Specific genes such as SLC7A11, TRIM16, TXNRD1, and SRXN1 show promise as pharmacodynamic biomarkers for APR-246.
  • These findings support the continued investigation of APR-246 in preclinical and clinical cancer studies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Organic Compounds03:02

Organic Compounds

All living things are formed mostly of carbon compounds called organic compounds. The category of organic compounds includes both natural and synthetic compounds that contain carbon. Although a single, precise definition has yet to be identified by the chemistry community, most agree that a defining trait of organic molecules is the presence of carbon as the principal element, bonded to hydrogen and other carbon atoms. However, some carbon-containing compounds such as carbonates, cyanides, and...
57.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K